1-3 of 3
Ronald Mihelic, PharmD, BCOP
Close
Sort by
Journal Articles

FLAG-Idarubicin Is Superior to Cytarabine Plus Idarubicin (7+3) for Initial Treatment of Acute Myeloid Leukemia (AML): A Multivariable Analysis of Patients Treated at a Single Center

Ronald Mihelic, PharmD, BCOP, Elizabeth Dickhaus, Pharm.D., Stacey Brown, B.A., Xu Zhang, PhD, Scott R. Solomon, MD, Lawrence E. Morris, MD, Asad Bashey, MD PhD, H. Kent Holland, MD
Journal: Blood
Blood (2014) 124 (21): 3728.
https://doi.org/10.1182/blood.V124.21.3728.3728
Published: 2014
Journal Articles

Outcomes Of Relapse Of AML Post Allogeneic Transplantation In The Era Of Hypomethylating Agents: An Analysis Of 162 Allogeneic Transplants From a Single Center

Justin LaPorte, PharmD, BCOP, Xu Zhang, PhD, Zaamin Hussain, Stacey Brown, BA, Connie A. Sizemore, PharmD, Melissa Sanacore, PharmD, Ronald Mihelic, PharmD, BCOP, Mindy Leech, PharmD, Lawrence E. Morris, MD, H. Kent Holland, MD, Scott R. Solomon, MD, Asad Bashey, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2086.
https://doi.org/10.1182/blood.V122.21.2086.2086
Published: 2013
Journal Articles

An Effective Hematopoietic Stem Cell Mobilization Algorithm for Adding Plerixafor to G-CSF for Multiple Myeloma Patients Undergoing Autologous Transplantation

Justin LaPorte, PharmD, BCOP, Scott R. Solomon, MD, Asad Bashey, MD, PhD, H. Kent Holland, MD, Lawrence E. Morris, Connie A. Sizemore, PharmD, Melissa Sanacore, PharmD, Ronald Mihelic, PharmD, BCOP, Mindy Leech, PharmD, Irina Grigorieva, PhD, Xu Zhang, PhD
Journal: Blood
Blood (2011) 118 (21): 4389.
https://doi.org/10.1182/blood.V118.21.4389.4389
Published: 2011